Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of a New Formula With a Reduced Concentration of Partially Hydrolyzed Protein on Growth of Healthy Term Infants: an Open-label Study

NCT03276663 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.

NCT NCT03276663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03276663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of a New Formula With a Reduced Concentration of Partially Hydrolyzed Protein on Growth of Healthy Term Infants: an Open-label Study
Lead sponsor
Société des Produits Nestlé (SPN)
Phase
Not applicable
Overall status
Completed
Start date
September 18, 2017
Completion date
June 3, 2020
Enrollment
194 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

growth